Meyka AI API is live for developers.Start building.
Advertisement
Karo Pharma AB (publ)

Karo Pharma AB (publ) (KARBF) Stock Overview

Explore Karo Pharma AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

KARBF●PNK
HealthcareDrug Manufacturers - Specialty & Generic
$5.25
$0.00(0.00%)
U.S. Market opens in 48h 46m
Advertisement

Karo Pharma AB (publ) (KARBF)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E RatioN/A
EPS (TTM)$0.02
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$3.38

KARBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Karo Pharma AB (publ) (KARBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $3.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-8.04%
3-Year Change
-8.04%
5-Year Change
-8.04%
All-Time (Max) Change
-8.04%

Contact Information

https://www.karopharma.com
46 1 03 30 23 10
Klara Norra Kyrkogata 33, Stockholm, NaN, 111 22

Company Facts

2,250 Employees
IPO DateApr 30, 2013
CountrySE

Frequently Asked Questions